3-aminopyrazole inhibitors of cyclin dependent kinases
CA 2399274 A1 · Owner: Bristol-Myers Squibb Company · Inventors: Kimball, Spencer David; Salvati, Mark E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention describes compounds of Formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds are protein kinase inhibitors and are useful in the treatment of proliferative diseases for , example, cancer, inflammation and arthritis. They may also be useful in the treatment of Alzheimer's disease, and cardiovascular disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 23, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 23, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 23, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.